3,577
Views
5
CrossRef citations to date
0
Altmetric
Perspective

Perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection

ORCID Icon, , , , ORCID Icon, , , & show all
Pages 421-430 | Received 22 Jan 2021, Accepted 16 Mar 2021, Published online: 26 Apr 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Rohan Ameratunga, See-Tarn Woon, Richard Steele, Klaus Lehnert, Euphemia Leung & Anna E. S. Brooks. (2022) Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Expert Review of Clinical Immunology 18:6, pages 557-565.
Read now
Rohan Ameratunga, See-Tarn Woon, Edward Lea, Richard Steele, Klaus Lehnert, Euphemia Leung & Anna E. S. Brooks. (2022) The (apparent) antibody paradox in COVID-19. Expert Review of Clinical Immunology 18:4, pages 335-345.
Read now
Rohan Ameratunga, See-Tarn Woon, Anthony Jordan, Hilary Longhurst, Euphemia Leung, Richard Steele, Klaus Lehnert, Russell Snell & Anna E. S. Brooks. (2021) Response to letter to the editor: the clinical utility of diagnostic T cell assays for COVID-19. Expert Review of Clinical Immunology 17:11, pages 1159-1161.
Read now
Sudeb C. Dalai & Lance Baldo. (2021) Letter to the editor regarding ‘perspective: diagnostic laboratories should urgently develop T cell assays for SARS-CoV-2 infection’. Expert Review of Clinical Immunology 17:11, pages 1155-1157.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.